Google Develops New AI Model

The artificial intelligence company "DeepMind," a subsidiary of the American technology company "Google," announced the development of a new type of AI model for medical research that can predict the structure and interactions of all molecules in life. According to Google DeepMind, owned by the "Alphabet" group, the new model "AlphaFold 3" goes beyond merely calculating proteins in any molecule to provide accurate predictions of protein interactions with other living components in human cells. The company "Isomorphic Labs," a London-based subsidiary of "DeepMind" specializing in the use of AI techniques in drug research, participated in the development of the new model. It is noteworthy that "DeepMind" previously developed the AI model "AlphaFold 2," which can create a three-dimensional shape of proteins. In 2020, DeepMind achieved a significant breakthrough in predicting protein structures. Since then, millions of researchers have used the AI model AlphaFold 2 to make discoveries in fields such as malaria vaccines, cancer treatments, and enzyme design. "DeepMind" showcased its new model "AlphaFold 3" in an article published in the scientific journal "Nature," a model that can predict the structure and interactions of all molecules in life with unprecedented accuracy.